Robert Schrepfer
2013
In 2013, Robert Schrepfer earned a total compensation of $1.3M as Vice President, New Business Development and Contract Manufacturing at ANI Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $98,000 |
|---|---|
| Option Awards | $1,115,169 |
| Salary | $91,404 |
| Total | $1,304,573 |
Schrepfer received $1.1M in option awards, accounting for 85% of the total pay in 2013.
Schrepfer also received $98K in non-equity incentive plan and $91.4K in salary.
Rankings
In 2013, Robert Schrepfer's compensation ranked 5,484th out of 12,286 executives tracked by ExecPay. In other words, Schrepfer earned more than 55.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,484 out of 12,286 | 55th |
Division Manufacturing | 1,912 out of 4,612 | 59th |
Major group Chemicals And Allied Products | 552 out of 1,462 | 62nd |
Industry group Drugs | 394 out of 1,156 | 66th |
Industry Pharmaceutical Preparations | 315 out of 890 | 65th |
Source: SEC filing on April 14, 2016.
Schrepfer's colleagues
We found six more compensation records of executives who worked with Robert Schrepfer at ANI Pharmaceuticals in 2013.
2013
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
2013
Charlotte Arnold
ANI Pharmaceuticals
Chief Financial Officer
2013
Stephen Simes
ANI Pharmaceuticals
Chief Executive Officer
2013
James Marken
ANI Pharmaceuticals
Vice President, Operations
2013
Phillip Donenberg
ANI Pharmaceuticals
Chief Financial Officer
2013
Robert Jamnick
ANI Pharmaceuticals